Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy.
Herpes simplex-induced fulminant hepatitis is an infrequently reported cause of hepatitis in adults. Pregnant females and patients with impaired cellular immunity may be at increased risk, although healthy adults have been affected. The diagnosis may be underrecognized due to nonspecific presenting symptoms and lack of typical cutaneous herpes lesions. We present three cases of fatal herpes simplex fulminant hepatitis. Our review of case reports of herpes simplex hepatitis in adults demonstrates improved survival with intravenous acyclovir therapy. We believe that empiric use of acyclovir should be considered while the diagnostic evaluation of non-acetaminophen-induced fulminant hepatitis is underway. Recognition of characteristic liver function abnormalities seen with fulminant herpes simplex hepatitis include marked elevation of transaminases with AST > ALT and a mild hyperbilirubinemia (anicteric hepatitis), and they should prompt acyclovir therapy. This is especially true when there are no obvious risk factors for other forms of hepatitis.
Department of Medicine, The Milton S. Hershey Medical Center, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
D J
DJ
Peters
W H
WH
Greene
F
F
Ruggiero
T J
TJ
McGarrity
D000212:Acyclovir / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D017809:Fatal Outcome; D005260:Female; D006561:Herpes Simplex / Q000150:complications*; D006801:Humans; D007275:Injections, Intravenous; D017093:Liver Failure / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged
D000212:Acyclovir